August 29, 2018

Media

Media & events

news

Lyndra Therapeutics Welcomes Dr. Patricia Hurter as Chief Executive Officer

June 3, 2019
Lyndra Therapeutics Welcomes Dr. Patricia Hurter as Chief Executive Officer Addition to management team strengthens Lyndra’s development capabilities WATERTOWN, Mass.,...
Read More

publications

  • Changing the Pill: Developments Toward the Promise of an Ultra-Long-Acting Gastroretentive Dosage Form
    Changing the Pill: Developments Toward the Promise of an Ultra-Long-Acting Gastroretentive Dosage Form
Expert Opinion
Expert Opinion
Changing the Pill: Developments Toward the Promise of an Ultra-Long-Acting Gastroretentive Dosage Form
Journal,  Expert Opinion on Drug Delivery ,  Volume 15, 2018 – Issue 12

Changing the pill: developments toward the promise of an ultra-long-acting gastroretentive dosage form

Pages 1189-1198 | Received 17 Jun 2018, Accepted 01 Nov 2018, Accepted author version posted online: 05 Nov 2018, Published online: 13 Nov 2018
URL : View Project

events

Lyndra Presents @ BIO International

Join us on Thursday, June 5th, at 5pm when Andrew Bellinger, our CSO, presents our 2019 Company Update at BIO International, Philadelphia Convention Center, Theater 4

2019 BIO International

awards

2019 Xconomy Awards Finalist in Startup Category

We are honored to be named a finalist for the Awards in the category for our work making daily pills a thing of the past.

#XconomyAwards